MC
UTHR icon

Machina Capital’s United Therapeutics UTHR Stock Holding History

Machina Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
2,200
+1,153
+110% +$574K 0.26% 143
2025
Q4 		$510K Buy
1,047
+374
+56% +$174K 0.1% 242
2025
Q3 		$282K Buy
+673
New +$226K 0.05% 285
2023
Q2 		– Sell
-200
Closed -$44.8K – 525
2023
Q1 		$44.8K Buy
+200
New +$49.3K 0.04% 331
2019
Q3 		– Sell
-964
Closed -$75K – 510
2019
Q2 		$75K Buy
964
+854
+776% +$79.9K 0.03% 380
2019
Q1 		$13K Buy
+110
New +$12.8K 0.01% 434

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Machina Capital's UTHR Position: Q1 2026 in Review

Machina Capital increased its United Therapeutics (UTHR) stake by 110% in Q1 2026, buying an estimated $574K and bringing the position to 2,200 shares worth $1.3M. The position accounts for 0.26% of the portfolio, ranked #143.

Machina Capital first reported a position in UTHR in Q1 2019 and has held it in 6 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Machina Capital held 2,200 shares of United Therapeutics worth $1.3M as of Q1 2026.
  • Machina Capital bought 1,153 United Therapeutics shares in Q1 2026, an estimated $574K.
  • United Therapeutics made up 0.26% of Machina Capital's portfolio in Q1 2026, its #143 holding.
  • Machina Capital first reported a position in United Therapeutics in Q1 2019 and has held it in 6 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Machina Capital's 13F filing for Q1 2026, filed 13 May 2026.